AGP Executive Report
Last update: 5 hours agoCardiovascular Research: A new REDUCE-IT® legacy analysis presented at the European Society of Cardiology Congress 2026 reports that highly adherent patients who stayed on icosapent ethyl for at least 1.5 years saw about a 30% relative reduction in major adverse cardiovascular events, while those who stopped early still showed a “legacy” benefit for the following years. Cancer & Screening: IARC marks Prostate Cancer Awareness Month 2026 with updated global figures: in 2024, prostate cancer was the second most common cancer in men and the fourth overall, with over 1.5 million cases worldwide; the agency highlights concerns about overdiagnosis linked to opportunistic PSA testing and calls for better-designed screening programmes. Public Health & Children’s Safety Online: New Zealand is moving toward a minimum age of 16 for access to social media and harmful gaming, following Australia’s under-16 social media ban; the focus is on protecting mental health, sleep, education, and reducing addictive design risks. Local Health Promotion Policy: Slovenia’s government issued a decree for mandatory contributions to promote Slovenian fruit in 2027–2029, aiming to boost consumption and competitiveness, with funding shared between the sector and the state. Medical Community Fundraising: Doctors in Glasgow are swapping clinical work for music—joining the European Doctors’ Orchestra to raise funds for Children’s Hospices Across Scotland (CHAS) ahead of a September 27 concert.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.